# HALOZYME THERAPEUTICS, INC. (HALO) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from HALOZYME THERAPEUTICS, INC.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/HALO/mda/fy2025/): filed 2026-02-17; accession 0001159036-26-000024 (https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/HALO/mda/fy2024/): filed 2025-02-18; accession 0001159036-25-000010 (https://www.sec.gov/Archives/edgar/data/1159036/000115903625000010/halo-20241231.htm)
- [FY 2023 MD&A](/company/HALO/mda/fy2023/): filed 2024-02-20; accession 0001159036-24-000008 (https://www.sec.gov/Archives/edgar/data/1159036/000115903624000008/halo-20231231.htm)
- [FY 2022 MD&A](/company/HALO/mda/fy2022/): filed 2023-02-21; accession 0001159036-23-000012 (https://www.sec.gov/Archives/edgar/data/1159036/000115903623000012/halo-20221231.htm)
- [FY 2021 MD&A](/company/HALO/mda/fy2021/): filed 2022-02-22; accession 0001159036-22-000014 (https://www.sec.gov/Archives/edgar/data/1159036/000115903622000014/halo-20211231.htm)

Back to /company/HALO/